Repro Med Systems Stock Investor Sentiment

KRMD Stock  USD 3.43  0.15  4.19%   
About 56% of all Repro Med's shareholders are looking to take a long position. The analysis of overall sentiment of trading Repro Med Systems stock suggests that some investors are interested at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
  

Repro Med Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
17 hours ago at finance.yahoo.com         
KORU Medical Systems, Inc. A Bull Case Theory
Yahoo News
over a week ago at businesswire.com         
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
businesswire News
over a week ago at www.macroaxis.com         
Acquisition by Linda Tharby of 127660 shares of Repro Med subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Piper Sandler Downgrades Koru Medical, Citing Valuation Concerns
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Acquisition by Wholihan Edward of 37 shares of Repro Med at 3.81 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over two weeks ago at simplywall.st         
CuriosityStream And 2 Other Promising Penny Stocks On US Exchange
Simply Wall St News at Macroaxis
over two weeks ago at businesswire.com         
Disposition of 16187 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
businesswire News
over three weeks ago at businesswire.com         
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in N...
businesswire News
over a month ago at finance.yahoo.com         
KORU Medical Systems Inc. is a Great Momentum Stock Should You Buy?
Yahoo News
over a month ago at zacks.com         
KORU Medical Systems Inc. is a Great Momentum Stock Should You Buy?
zacks News
over a month ago at www.macroaxis.com         
Acquisition by Cascella Robert of 19000 shares of Repro Med at 2.607 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 1000000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
KORU Medical Systems Issues Press Release on Preliminary Financial Results-
news
over a month ago at finance.yahoo.com         
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results Achieves Record F...
Yahoo News
over a month ago at seekingalpha.com         
KORU Medical Systems reports record Q4 and FY24 revenue
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Med Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
KORU Medical Systems versus Cytosorbents Head to Head Contrast
12/10/2024
2
Acquisition by Manko Joseph M. Jr. of 37 shares of Repro Med subject to Rule 16b-3
12/31/2024
3
Acquisition by French Donna of 37 shares of Repro Med at 3.81 subject to Rule 16b-3
01/03/2025
4
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results Achieves Record Full Year and Quarterly Revenues Positive Cash Flow for the F...
01/13/2025
5
Disposition of 1000000 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
01/21/2025
6
Acquisition by Cascella Robert of 19000 shares of Repro Med at 2.607 subject to Rule 16b-3
01/23/2025
7
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
01/30/2025
8
Acquisition by Wholihan Edward of 37 shares of Repro Med at 3.81 subject to Rule 16b-3
02/14/2025
9
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
02/19/2025

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.